Oncology
    
    
  
  News
Abiraterone reduced morbidity in mCRPC patients
Major finding: The time of radiographic progression-free survival was doubled in patients given abiraterone and prednisone relative to those given...
News
Kadcyla wins FDA approval for late-stage breast cancer
News
Clinical staging of early esophageal cancer unreliable
Major Finding: Of 482 patients who went directly to surgery, 26% were downstaged, while 47% were upstaged.Data Source: A retrospective, database...
News
Survival higher with surveillance of small kidney tumors
Major Finding: After 36 months, patients were 63% less likely to have died if their tumors were managed by surveillance instead of surgery (HR, 0....
News
Shorter androgen blockade okay in localized prostate cancer
Major Finding: At 5 years, overall survival was 92% in the 36-month group and 87% in the 18-month group; disease specific survival was 98% and 96...
News
Age, race impact prostate cancer risk
Major Finding: Men aged 75 years or older accounted for 12% of the population, but for 24% of intermediate-risk and 26% of high-risk disease.Data...
News
Survival shorter in young gastric cancer patients
Major Finding: Patients diagnosed with gastric adenocarcinoma before age 40 years lived a median of 5 months; older patients lived a median of 8...
News
Breast-conserving therapy improved survival over mastectomy
Major Finding: Women who underwent lumpectomy for stage I or II breast cancer were 28% less likely to die from any cause and up to 16% less likely...
News
Cancer survival still lower for African Americans
Conference Coverage
New tool predicts late recurrence in breast cancer
Major Finding: Among patients who remained disease free at 5 years, the 61% with a low baseline BCI score had a 3.5% rate of distant recurrence...
News
Resecting residual gastrointestinal stromal tumors improved survival
Major Finding: Time to tumor progression was 88 months in 42 patients who had surgery for residual disease and 42 months in 92 patients given...
 
                             